High‑Dose Amoxicillin Recommendations for Pediatric Respiratory Infections

Community‑Acquired Pneumonia (CAP)

• First‑line therapy: For children older than 3 months with pneumococcal pneumonia, high‑dose amoxicillin (80–90 mg/kg/day divided twice daily) is the preferred regimen. 1
• Treatment duration: A 5‑day course provides cure rates comparable to 10 days in uncomplicated outpatient CAP. 2

Acute Otitis Media (AOM)

• Standard‑dose option: In children ≥ 2 years with mild‑to‑moderate AOM and no recent antibiotic exposure, standard‑dose amoxicillin (45 mg/kg/day divided twice daily) is appropriate. 3
• High‑dose indication: High‑dose amoxicillin (80–90 mg/kg/day BID) should be used when any risk factor is present (e.g., daycare attendance, antibiotic use within the past 30 days, age < 2 years, or severe symptoms). 2
• Treatment duration: A 10‑day course is recommended for AOM despite emerging data on shorter courses. 2

Acute Bacterial Sinusitis

• Standard‑dose option: For children ≥ 2 years with mild disease and no recent antibiotics, standard‑dose amoxicillin (45 mg/kg/day BID) is acceptable. 3
• High‑dose option: Moderate‑to‑severe illness or presence of risk factors (e.g., daycare, recent antibiotics) warrants high‑dose amoxicillin‑clavulanate (amoxicillin component 80–90 mg/kg/day BID). 2
• Treatment duration: A 10‑day course is advised for acute bacterial sinusitis. 2

Rationale for High‑Dose Therapy

• Pharmacodynamic advantage: High‑dose amoxicillin achieves middle‑ear and sinus fluid concentrations sufficient to overcome intermediate Streptococcus pneumoniae resistance. 2
• Resistance threshold: When community pneumococcal resistance exceeds 10 %, high‑dose therapy should be initiated. 2

Risk Factors Prompting High‑Dose Amoxicillin

• Presence of any of the following triggers high‑dose therapy: daycare attendance, antibiotic use within the prior 30 days, age < 2 years, moderate‑to‑severe illness, or community pneumococcal resistance > 10 %. 2

Dosing Frequency

• Twice‑daily dosing: The high‑dose regimen (80–90 mg/kg/day) should be divided into two doses per day; this schedule is as effective as three‑times‑daily dosing and improves adherence. 2

When to Escalate to Amoxicillin‑Clavulanate

• Switch to amoxicillin‑clavulanate if β‑lactamase‑producing Haemophilus influenzae is suspected, if treatment failure occurs after 48–72 h of amoxicillin, or if the illness is severe and requires broader coverage. [2][3]

When to Add a Macrolide (Not Substitute)

• Consider adding a macrolide in children > 5 years with persistent symptoms after 48 h, when atypical pathogens such as Mycoplasma pneumoniae are suspected, or when the clinical condition remains stable but symptoms continue. [3][2]

Amoxicillin Dosing Recommendations for Pediatric Infections

Standard vs. High‑Dose Recommendations

• PIDS/IDSA recommends amoxicillin 90 mg/kg/day in two divided doses for infections caused by Streptococcus pneumoniae to ensure adequate coverage of resistant strains (strong guideline recommendation) 4.
• The American Academy of Pediatrics (AAP) recommends 80–90 mg/kg/day for acute bacterial sinusitis in children with moderate‑to‑severe illness, recent antibiotic exposure, daycare attendance, or age < 2 years (strong recommendation) 5.
• For severe lower‑respiratory‑tract infections, the FDA approves 45 mg/kg/day in divided doses every 12 hours (moderate‑strength evidence) – this translates to ~540 mg per dose for a 24 kg child (not directly cited, but derived from FDA dosing).

Risks Associated with Underdosing

• Lower amoxicillin doses increase the risk of treatment failure, especially against organisms with intermediate resistance (moderate‑quality evidence) [4][6].
• Subtherapeutic dosing promotes selection of resistant S. pneumoniae strains with altered penicillin‑binding proteins (moderate‑quality evidence) [4][5].

Benefits of High‑Dose Therapy

• High‑dose amoxicillin (80–90 mg/kg/day) achieves sinus and middle‑ear fluid concentrations sufficient to overcome intermediate resistance (moderate‑quality evidence) 5.
• A dose of 1080 mg every 12 hours (90 mg/kg/day) is indicated when community pneumococcal resistance exceeds 10 %, the child has recent antibiotic exposure, attends daycare, is < 2 years old, or has experienced prior treatment failure (strong guideline recommendation) [5][4]6.

Duration of Therapy

• A 10‑day course is appropriate for streptococcal pharyngitis (to prevent rheumatic fever) and for acute otitis media in young children (strong recommendation) 5.

High‑Dose Amoxicillin Recommendations for Children (Weight‑Based Dosing)

Community‑Acquired Pneumonia (CAP)

• First‑line regimen: For a child weighing approximately 35 kg, prescribe amoxicillin 80–90 mg/kg/day (total 2 800–3 150 mg per day), divided into two doses every 12 hours. This high‑dose schedule is endorsed by the Infectious Diseases Society of America (IDSA) for pneumococcal pneumonia. 7

Group A Streptococcal Pharyngitis

• Recommended dose: Amoxicillin 50–75 mg/kg/day in two divided doses (total 1 750–2 625 mg per day for a 35 kg child) is advised to ensure bacterial eradication and to prevent acute rheumatic fever. 7

Adjunctive Therapy When Symptoms Persist

• Adding a macrolide: In children older than 5 years who have ongoing respiratory symptoms after 48 hours and in whom atypical pathogens (e.g., Mycoplasma pneumoniae) are suspected, a macrolide should be added to the amoxicillin regimen rather than substituted. 7

Severe Acute Malnutrition

• Dose unchanged: Severely malnourished children should receive the same weight‑based amoxicillin doses as well‑nourished children, provided they do not have severe diarrhea, renal failure, or shock. 8

• Pharmacokinetic support: Studies show that amoxicillin absorption and clearance are largely unaffected by severe malnutrition, justifying the use of standard weight‑based dosing in this population. 8

Amoxicillin Oral Suspension: Pediatric Dosing, Indications, and Management

Formulations

• The FDA‑approved oral suspension is available in standard concentrations of 125 mg/5 mL, 200 mg/5 mL, 250 mg/5 mL, and 400 mg/5 mL, enabling accurate weight‑based dosing. 9

General Dosing Principles

• Amoxicillin suspension is the preferred first‑line liquid antibiotic for children, with total daily doses ranging from 45 mg/kg (standard) to 90 mg/kg (high) divided twice daily; the choice depends on infection type, severity, and presence of resistance risk factors. [10][11]12

Dosing by Specific Indication

Community‑Acquired Pneumonia (CAP)

• High‑dose amoxicillin 90 mg/kg/day (divided BID) is recommended for Streptococcus pneumoniae isolates with penicillin MIC > 2.0 µg/mL. [10][11]12
• For less resistant strains, a standard dose of 45 mg/kg/day given three times daily may be used. 10

Group A Streptococcal Pharyngitis

• Standard dosing of 50 mg/kg/day divided BID for a mandatory 10‑day course is advised to prevent acute rheumatic fever. 11
• An alternative regimen of 50–75 mg/kg/day divided BID is also acceptable. 9

Acute Bacterial Sinusitis

• In children ≥2 years with mild disease and no recent antibiotic exposure, a standard dose of 45 mg/kg/day divided BID is appropriate. 13
• When risk factors for resistance are present, a high dose of 80–90 mg/kg/day divided BID should be used. 13
• Treatment duration may be 10 days or 7 days after symptom resolution, whichever is completed first. 13

Risk Factors Prompting High‑Dose Therapy

• High‑dose amoxicillin (80–90 mg/kg/day) should be initiated if any of the following are present: age < 2 years, and moderate‑to‑severe illness. (Age < 2 years cited by 13; moderate‑to‑severe illness cited by 12.) [13][12]

Pharmacodynamic Rationale

• High‑dose regimens achieve middle‑ear and sinus fluid concentrations that overcome intermediate S. pneumoniae resistance mediated by altered penicillin‑binding proteins. 13

Escalation to Amoxicillin‑Clavulanate

• Switch to high‑dose amoxicillin‑clavulanate (amoxicillin component 80–90 mg/kg/day plus clavulanate 6.4 mg/kg/day, divided BID) when β‑lactamase‑producing Haemophilus influenzae or Moraxella catarrhalis is suspected, or when local prevalence of such organisms is high. 13
• Escalate in cases of severe illness requiring broader antimicrobial coverage. 12

Adjunctive Macrolide Therapy

• In children >5 years with persistent symptoms after 48 hours and suspicion for atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae), add (do not replace) a macrolide to the β‑lactam regimen. [10][11]

Clinical Pitfalls to Avoid

• Do not use standard‑dose amoxicillin when any resistance risk factor is present, as this raises treatment‑failure risk. 13
• Do not substitute a macrolide for amoxicillin in pneumonia; macrolides should be added only when atypical pathogens are suspected. [10][11]
• Do not employ amoxicillin‑clavulanate as first‑line therapy unless β‑lactamase‑producing organisms are suspected or prior amoxicillin therapy has failed. 13

High‑Dose Amoxicillin and Amoxicillin‑Clavulanate Recommendations for Pediatric Infections

Indications for High‑Dose Amoxicillin (80–90 mg/kg/day)

• The Pediatrics guideline (2013) recommends escalating to high‑dose amoxicillin (80–90 mg/kg/day divided twice daily) for children who have risk factors for resistant organisms, such as attendance at a daycare setting. 14

• High‑dose amoxicillin is specifically advised for severe acute otitis media, community‑acquired pneumonia, acute bacterial sinusitis when risk factors are present, and infections that require enhanced pneumococcal coverage. 14

Infection‑Specific Dosing Recommendations

• For mild acute bacterial sinusitis without risk factors, the guideline advises standard‑dose amoxicillin (45 mg/kg/day divided twice daily) for a 10‑day course. 14

• For moderate‑to‑severe acute bacterial sinusitis or when risk factors exist, the guideline recommends high‑dose amoxicillin‑clavulanate (amoxicillin component 80–90 mg/kg/day plus clavulanate 6.4 mg/kg/day) divided twice daily. 14

Criteria to Switch from Amoxicillin Monotherapy to Amoxicillin‑Clavulanate

• Lack of clinical improvement after 48–72 hours of amoxicillin monotherapy warrants escalation to high‑dose amoxicillin‑clavulanate. 14

• Suspected infection with β‑lactamase‑producing Haemophilus influenzae or Moraxella catarrhalis should be treated with high‑dose amoxicillin‑clavulanate. 14

• High local prevalence of β‑lactamase‑producing organisms is another indication to switch to amoxicillin‑clavulanate. 14